In its upcoming semi-annual list of stocks, Association of Mutual Funds in India (AMFI) is highly likely to downgrade and One 97 Communication ( Paytm) from largecap to midcap category, according to a report by . The AMFI rejig will majorly be classified by size, taking into account data from July to December 2022. This … Read more
Brokerage firm Ashika Stock Broking has a buy rating on while has retained a buy call on . Phillip Capital also has a buy on . We have collated a list of recommendations from top brokerage firms: Ashika Stock Broking on Mirza International: Buy| Target Rs 370| LTP Rs 311| Upside 19%Ashika Stock Broking maintained … Read more
Shares of fell as much as 24% to Rs 1,681 per share in the last three trading sessions on the BSE after the company reported a fall of 20.14% in consolidated net profit to Rs 241.24 crore due to lower sales and higher expenses. In the second quarter of FY22, the profit after tax (PAT) … Read more
New Delhi: Shares of dropped 15% during the trading session on Thursday, registering its biggest intra-day loss in more than two years of listing at the bourses following a disappointing Q2 performance. The drug maker, which announced its results for the September 2022 quarter, reported a 20% year-on-year (YoY) decline in consolidated net profit at … Read more
New Delhi: Domestic equity markets ended the week on a higher note, extending the gains on the back of upbeat earnings from India Inc and supportive global cues. Both benchmark indices – BSE Sensex and Nifty50- jumped more than 2 per cent each. Midcap and smallcap indices also ended in red, whereas fear gauge index … Read more
Mumbai: Varun Beverages, , , and are likely to find a place in the large-cap category in the Association of Mutual Funds in India’s (AMFI‘s) semi-annual re-categorisation. , Metro Brands, , and Fine Organic are expected to enter the mid-cap category, according to Nuvama Alternative & Quantitative Research. AMFI will officially announce the new list … Read more
Global brokerage firm CLSA maintained outperform rating on as well as and a buy rating on . Goldman Sachs, meanwhile, initiated coverage on with a buy rating. We have collated a list of recommendations from top global brokerage firms from ETNow: CLSA on UltraTech Cement and Dalmia Bharat:CLSA maintained outperform rating on UltraTech Cement and … Read more
The US economy also witnessed substantial issues in its pharma market. In addition to these, manufacturing & exporting countries around the world saw heightened raw material price inflation followed by supply chain disruption. All these affected the margins of the companies deeply. Synopsis Indian pharmaceutical market flattened after the pandemic led to a massive upsurge … Read more
New Delhi: Despite strong volatility seen in sectors like metal, mining and pharma, global brokerage firms are bullish on select stocks from these pockets. Global brokerage Citi remains bullish on , maintaining a buy rating on the counter. However, it has slashed its target price to Rs 1,085 from Rs 1,800, signalling about a 25 … Read more
Without making big national headlines, China’s Gland Pharma launched the biggest initial public offering (IPO) of shares in Indian pharmaceutical history of Rs 6,500 crore in November. This was oversubscribed more than twice, despite calls for boycotting everything Chinese after the Ladakh clash last summer when 20 Indian soldiers died. Gland Pharma’s issue price was … Read more